3rd ESO-ESMO Latin-American Masterclass in Clinical Oncology

Chairs: A. Cervantes, ES - N. Pavlidis, GR - R.A. Stahel, CH
Scientific Co-ordinators: M. Aapro, CH - F. Cardoso, PT


FOREWORD
The Masterclass is the most structured ESO educational activity whose format has been established and presented in Europe for over a decade. The success of the teaching method has been confirmed by the events held also in other parts of the world as well as by the first and second edition of the Latin American Masterclass held in Brazil and Colombia in 2015 and 2016. It is with pleasure and gratefulness for the consideration of the local community, that ESO announces the third edition to be held in the region in 2017. The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments.
State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and small groups and discuss them with the chairs and the faculty. As for all Masterclasses, the number of participants will be limited and admission will be by competitive application only. Admitted participants will be granted free registration and half-board accommodation for the duration of the Masterclass.


TEACHING FORMAT
The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages.
The clinical sessions will be complemented by tumour board discussions supported by regional tutors. Furthermore, participants will deliver case presentations within small groups and discuss these with the chairs and the faculty. All participants will reside at the course venue and participation is compulsory throughout the course.
The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.


LEARNING OBJECTIVES
• Improve medical oncologists’ skills
• Practising case discussions
• Deep focus on breast, gastro-intestinal, genitourinary, gynaecological, head and neck and lung cancers
• Compact update on further topics of interest


THE MASTERCLASS IS
• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• Delivered by an international faculty of experts

The Latin-American Masterclass in Clinical Oncology is an ESO-ESMO joint event
Under the auspices of

ORGANISING SECRETARIAT
European School of Oncology
Piazza Indipendeza 2, 6500 Bellinzona, Switzerland

Luis Carvalho, Ph: +41 91 820 09 58, E-mail: lcarvalho@eso.net
Laura Richetti, Ph: +41 91 820 0951, E-mail: lrichetti@eso.net


LANGUAGE
The Masterclass will be held in English and translation will not be provided.


INSURANCE AND SAFETY INFORMATION
The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants and faculty members are advised to take out their own personal and travel insurance coverage, take appropriate security measures and exercise caution in public places.


CME ACCREDITATION AND CERTIFICATES
Participants will be entitled to receive a certificate of attendance at the close of the Masterclass by completing the online evaluation questionnaire.
The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The evaluation of the event has been performed by the Accreditation Council of Oncology in Europe (ACOE) that acknowledged the quality of the scientific programme and its educational value. The event is designated for a maximum of 24 European CME credits (ECMEC).
Through an agreement between UEMS and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.
Furthermore, the conference has been accredited with 25 ESMO-MORA category 1 points.


ESO CLINICAL TRAINING CENTRES FELLOWSHIP PROGRAMME
The ESO Clinical Training Centres Fellowship programme gives doctors who have specialized within the last 5 years the opportunity to request a training period of 3 or 6 months at one of the CTC Centres in Europe.
In Latin America only those who have taken part in the ESO-ESMO Latin-American Masterclass in Clinical Oncology and who meet the requirements can apply!
For further details please visit www.eso.net/varie/clinical-training-centres.html


ACKNOWLEDGEMENTS
The Latin-American Masterclass in Clinical Oncology is supported through ESO and ESMO funding and unrestricted educational grant provided by Roche.

FACULTY
M.S. Aapro, Clinique de Genolier, Genolier, CH
J. Baptista, University of Costa Rica, Hospital San Juan de Dios, San Jose, CR
F. Calvo, Hospital General Universitario Gregorio Marañon, Madrid, ES
E. Cambronero, Centro de Cancer Metropolitano, San Jose, CR
F. Cardoso, Champalimaud Cancer Center, Lisbon, PT
P. Casali, National Cancer Institute, Milan, IT (in videoconference)
F. Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, CH
A. Cervantes, University Clinical Hospital, Valencia, ES
L. Corrales, CCSS (Caja Costaricense de Seguro Social), San Jose, CR
G. Curigliano, European Institute of Oncology, Milan, IT
M. Del Pilar Estevez Diz, Inituto do Cancer do Estado de Sao Paulo, Sao Paulo, BR
S.X. Franco, Clinical del Country, Bogota, CO
A. Frasson, Hospital Israelita Albert Einstein, Sao Paulo, BR
J.P. Garbanzo, CCSS (Caja Costaricense de Seguro Social), San Jose, CR
F. Geara, The American University of Beirut Medical Center, Beirut, LB
F. Gomez, Fundacion Santa fe de Bogota, CO
S. Litière, European Organisation for Research and Treatment of Cancer EORTC, Brussels, BE
C. Medina, Fundacion Santa fe de Bogota, CO
N. Mottet, University Jean Monnet, Saint Etienne, FR
N. Pavlidis, University Hospital, Ioannina, GR
F.A. Peccatori, European School of Oncology and European Institute of Oncology, Milan, IT
F. Penault-Llorca, Centre Jean Perrin, Clermont-Ferrand, FR
A.C. Rodriguez, INCIENSA Foundation, Guanacaste, CR
R.A. Stahel, University Hospital, Zurich, CH
R.M. Terra, University of São Paulo Medical School, São Paulo, BR
E. Van Cutsem, University Hospital Gasthuisberg, Leuven, BE
J.B. Vermorken, University Hospital Antwerp, Edegem, BE
S. Wang, CCSS (Caja Costaricense de Seguro Social), San Jose, CR
G. Werutsky, Latin American Cooperative Oncology Group, Porto Alegre, BR
Z. Zeledon, University of Costa Rica, Hospital San Juan de Dios, San Jose, CR
W. Zoss, RINC (Network of national cancer institutes and institutions), Rio de Janeiro, BR
C. Zuniga Orlich, Hospital San Juan de Dios, San Jose, Costa Rica, CR

 26 April

14:15		Welcome and introduction    Chairs and Coordinators
14:20		Spotlight session The magnitude of the cancer problem in my country C. Zuniga Orlich, CR
14:45		Discussion
14:55		Clinical session Genito-urinary cancers (I)    Chair: N. Mottet, FR Prostate cancer:
		Active surveillance or watchful waiting F. Gomez, CO
		Local therapy: Surgery and radiotherapy    F. Geara, LB
		First-line endocrine treatment   N. Mottet, FR
		Endocrine-resistant-refractory    N. Mottet, FR
		Discussion
17:10		Coffee break
17:30		Clinical session Genito-urinary cancers (II)    Chair: C. Medina, CO
		Treatment of bladder cancer   N. Mottet, FR
		Metastatic renal cancer: Evidence-based treatment    C. Medina, CO
19:10		Tumour board Genito-urinary cancers   Participants' case presentations Faculty and tutors: F. Gomez, CO - C. Medina, CO
20:30		Dinner

 

 27 April

8:30		Clinical session Breast cancer (I)    Chair: G. Curigliano, IT
		What the clinician needs to know about breast pathology and sample quality    F. Penault-Llorca, FR
		(Neo-) adjuvant chemotherapy and biological agents    G. Curigliano, IT
		(Neo-) adjuvant endocrine therapy    F. Cardoso, PT
		Optimal loco-regional management of breast cancer A. Frasson, BR
		Discussion
10:30		Coffee break
10:40		Clinical session Breast cancer (II)    Chair: F. Cardoso, PT
		Recommended management of HER-2+ advanced breast cancer    F. Cardoso, PT
		Recommended management for triple-negative advanced breast cancer    G. Curigliano, IT
		Recommended management for ER+ advanced breast cancer    S.X. Franco, CO
		Discussion
12:30		Tumour board Breast cancer    Participants’ case presentations Moderator: M.S. Aapro, CH Faculty and Tutors: A. Frasson, BR - S.X. Franco, CO
13:30		Lunch
14:30		Spotlight session Clinical trial management    Chair: F. Cardoso, PT
		The reality of clinical trials in Latin America G. Werutsky, BR
		Critically assessing published clinical trials: The danger of bias and wrong interpretations S. Litière, BE
		Discussion
16:00		Coffee break
16:20		Spotlight session Management of cancer in young women F. Cardoso, PT
		Discussion
17:00		Spotlight session Fertility preservation and cancer in pregnancy F.A. Peccatori, IT
		Discussion
17:55		Spotlight session Management and treatment of toxicity M.S. Aapro, CH
		Discussion
18:50		Spotlight session Advancing cancer control in Latin America: the case of RINC/UNASUR W. Zoss, BR
		Discussion

 

 28 April

8:30		Clinical session Gynaecological cancers    Chair: J.B. Vermorken, BE
		New classification of gynaecological cancers F. Penault Llorca, FR
		Ovarian cancer: Surgical and systemic treatment    J.B. Vermorken, BE
		Cervical cancer: Primanry and secondary prevention    A.C. Rodriguez, CR
		Cervical cancer: Systemic treatment     M. Del Pilar Estevez Diz, BR
		Management of endometrial cancer   J.B. Vermorken, BE
		Radiotherapy of gynaecological malignancies    F. Geara, LB
11:20		Coffee break
11:40		Tumour board Gynaecological cancers    Participants’ case presentations Faculty and Tutor: M. Del Pilar Estevez Diz, BR
12:10		Spotlight session ancer of unknown primary   N. Pavlidis, GR
12:50		Lunch
14:00		Clinical session Head and neck cancer    Chair: J.B. Vermorken, BE
		When to operate? E. Cambronero, CR
		When to irradiate? F. Calvo, ES
		Systemic therapy and radio-chemotherapy J.B. Vermorken, BE
		Discussion
16:05		Tumour board Head and neck cancer    Participants’ case presentations Faculty and Tutor: E. Cambronero, CR
16:40		Coffee break
17:00		Group sessions (three/four groups)    Chairs and Coordinators, and regional tutor for each group Tutors: J. Baptista, CR - L. Corrales, CR - S. Wang, CR Part I: Participants’ clinical case presentations Part II: Selected participants present their national situation ("How is cancer treated in my country")

 

 29 April

8:30		Clinical session Gastro-intestinal tumours (I)    Chair: A. Cervantes, ES
		Adjuvant and neo-adjuvant treatment of colorectal cancer    E. Van Cutsem, BE
		Systemic treatment in advanced disease (including liver)    E. Van Cutsem, BE
		Discussion
9:50		Coffee break
10:10		Clinical session Gastro-intestinal tumours (II)    Chair: E. Van Cutsem, BE
		Management of rectal cancer : Any role for adjuvant chemotherapy?    A. Cervantes, ES
		Systemic treatment in early and advanced gastric cancers    A. Cervantes, ES
		Pancreatic and biliary tract cancers    E. Van Cutsem, BE
		Discussion
12:10		Tumour board Gastro-intestinal tumours   Participants’ case presentations Faculty and Tutors: J.P. Garbanzo, CR - Z. Zeledon, CR
13:10		Lunch
14:10		Spotlight session ESMO guidance on evaluation of treatment benefit R.A. Stahel, CH
		Discussion
14:50		Spotlight session MALT lymphoma F. Cavalli, CH
		Discussion
15:30		Spotlight session Sarcoma and GIST P. Casali, IT (videoconf.)
16:10		Coffee break
16:30		Group sessions (three/four groups)  Chairs and Coordinators, and regional tutor for each group Tutors: J. Baptista, CR - L. Corrales, CR - S. Wang, CR Part I: Participants’ clinical case presentations Part II: Selected participants present their national situation ("How is cancer treated in my country")
19:45		Farewell dinner

 

 30 April

8:30		Clinical session Lung cancer (I)    Chair: R.A. Stahel, CH
		Molecular classification of lung cancer for clinical practice F. Penault-Llorca, FR
		Surgery    R.M Terra, BR
		Radiotherapy    F. Calvo, ES
		Non-small cell lung cancer systemic therapy    R.A. Stahel, CH
		Discussion
11:00		Coffee break
11:20		Clinical session Lung cancer (II)   Chair: R.A. Stahel, CH
		Small cell lung cancer    R.A. Stahel, CH
		Discussion
11:55		Tumour board Lung cancer   Participants’ case presentations Faculty and Tutors: R. Terra, BR - L. Corrales, CR
12:55		Learning assessment test
13:30 -14:30		Lunch followed by departures